Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Wright

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 13, 2002
The double-edged sword of COX-2 selective NSAIDsJames M Wright
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 27, 2005
Are the benefits of statins a class effect?James M Wright
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 20, 2007
Progressive drug licensing: an opportunity to achieve transparency and accountability?James M Wright
International Journal of Clinical Practice|June 20, 2007
Practice guidelines by specialist societies are surprisingly deficientJames M Wright
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 26, 2003
Why don't we initiate more large simple randomized controlled trials?James M Wright
Journal of Hypertension|April 14, 2006
Estimation of attributable burden of disease: authors' replyFrancois Gueyffier, James M Wright
International Journal of Occupational and Environmental Health|May 4, 2012
Rosuvastatin and the JUPITER trial: critical appraisal of a lifeless planet in the galaxy of primary preventionAntonio López, James M Wright
Canadian Family Physician Medecin De Famille Canadien|March 7, 2003
Case report: prescribing caution. When a simple disease isn't so simpleCremona Ticea, James M Wright
Plos One|May 30, 2009
Factors affecting blood pressure variability: lessons learned from two systematic reviews of randomized controlled trialsVijaya M Musini, James M Wright
The Cochrane Database of Systematic Reviews|July 10, 2009
First-line drugs for hypertensionJames M Wright, Vijaya M Musini
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 13, 2002
The double-edged sword of COX-2 selective NSAIDsJames M Wright
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 27, 2005
Are the benefits of statins a class effect?James M Wright
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 20, 2007
Progressive drug licensing: an opportunity to achieve transparency and accountability?James M Wright
International Journal of Clinical Practice|June 20, 2007
Practice guidelines by specialist societies are surprisingly deficientJames M Wright
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 26, 2003
Why don't we initiate more large simple randomized controlled trials?James M Wright
Journal of Hypertension|April 14, 2006
Estimation of attributable burden of disease: authors' replyFrancois Gueyffier, James M Wright
International Journal of Occupational and Environmental Health|May 4, 2012
Rosuvastatin and the JUPITER trial: critical appraisal of a lifeless planet in the galaxy of primary preventionAntonio López, James M Wright
Canadian Family Physician Medecin De Famille Canadien|March 7, 2003
Case report: prescribing caution. When a simple disease isn't so simpleCremona Ticea, James M Wright
Plos One|May 30, 2009
Factors affecting blood pressure variability: lessons learned from two systematic reviews of randomized controlled trialsVijaya M Musini, James M Wright
The Cochrane Database of Systematic Reviews|July 10, 2009
First-line drugs for hypertensionJames M Wright, Vijaya M Musini
Pageof 17